Oxford University doctors and scientists are starting the first safety trial of an experimental preventative Ebola vaccine regimen being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen).The Oxford Vaccine Group, part of the University of Oxford Department of Paediatrics, aims to have vaccinated all 72 healthy adult volunteers by the end of January.\r\n \r\n
Today\u2019s Research Excellence Framework (REF 2014) results confirm the University of Oxford\u2019s world leading position in medical sciences research.
The rapid evolution of HIV, which has allowed the virus to develop resistance to patients' natural immunity, is at the same time slowing the virus' ability to cause AIDS, according to new research Funded by the Wellcome Trust.
Medical professionals used to believe that babies simply don\u2019t feel pain. Building on critical work started in Oxford in the 1980s that proved them wrong, Dr Rebeccah Slater is developing new ways to see inside the minds of newborns.
The HIV Research Group, led by Professor Philip Goulder of the Department of Paediatrics, have been awarded a multi-million pound, five year Wellcome Trust Senior Investigator award to further their work into HIV disease limitation.
The Oxford Vaccine Group, part of the University of Oxford Department of Paediatrics, have been successful in gaining funding from the European Vaccine Initiative and the Bill and Melinda Gates Foundation for new research into Salmonella Paratyphii.
Oxford Vaccine Group director and Professor of Paediatric Infection at the Department of Paediatrics, Professor Andrew Pollard, discusses the work of the Oxford Vaccine Group
On March 21st 2014 the MenB vaccine was recommended for introduction into the UK schedule. In this short film, experts and a mother whose child was disabled by MenB infection talk about the new vaccine.
Professor Irene Roberts, Professor of Paediatric Haematology at the University of Oxford Department of Paediatrics, has been appointed as Theme Lead for Non-Malignant Haematological Disorders for the National Institute of Health Research Rare Diseases Translational Research Collaboration.
![\"\"](\"https://www.paediatrics.ox.ac.uk/news/oxford-vaccine-group-begins-first-trial-of-new-ebola-vaccine-1/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n